Investigation
CBG: a promising biomarker to detect recent cannabis use

A groundbreaking study published in the journal Clinical Toxicology revealed an innovative approach to cannabis detection: the use of Cannabigerol (CBG) as a biomarker to identify recent cannabis use. Unlike other cannabinoids, CBG, a minor cannabinoid, emerges as an effective indicator of recent cannabis use. This discovery could help clarify forensic investigations and understand whether there has been recent use of cannabis in scenarios such as car accidents or workplace incidents, where detecting cannabis intoxication can be crucial.
In a comprehensive investigation conducted by Denver Health and Colorado University, 56 individuals participated, of which 32 were daily cannabis consumers and 24 were occasional consumers. Each participant consumed cannabis as they normally would, with blood samples taken immediately before and 30 minutes after consumption. The results were surprising: CBG was detected in 28 participants after smoking, highlighting its potential as an indicator of recent cannabis use.
CBG vs. THC: The crucial distinction
The importance lies in the unique characteristics of CBG. Unlike THC, the main psychoactive compound in cannabis, CBG dissipates quickly from the bloodstream. This fleeting presence makes CBG an ideal marker for recent cannabis use, especially in scenarios such as car accidents or workplace incidents, where detection of active cannabis intoxication is crucial.
Accuracy of CBG as a Biomarker
O study established that a whole blood CBG concentration equal to or greater than 0,2 milligrams per liter (mg/L) had 96% specificity, 50% sensitivity and 73% accuracy in identifying cannabis consumption in the last 30 minutes. Although CBG proves to be highly specific but less sensitive, it serves as a valuable complement to other cannabinoids in blood in forensic investigations.
Challenges and future perspectives: Beyond THC
However, challenges to these findings remain. The study did not measure the exact amount of CBG present in the cannabis consumed, which limits accurate correlations. Furthermore, the time period for collecting blood samples may not correspond to real-life forensic situations and the effects of cannabis can still vary greatly from person to person. However, ongoing research explores the behaviors of various cannabinoids in the body after cannabis consumption, paving the way for a more comprehensive understanding of cannabis detection.
Unlike alcohol detection, cannabis intoxication poses complex challenges. THC, which remains in the body for weeks after use, complicates accurate detection. Study investigators are actively researching the pharmacokinetics of various cannabinoids following inhalation, with the goal of identifying additional biomarkers for cannabis use. Furthermore, as the market for broad-spectrum CBD products expands, it becomes imperative to consider their impact on blood cannabinoid levels, which increases the complexity of methods for detecting cannabis use.
In conclusion, this pioneering study lights the way to a more nuanced and accurate cannabis detection system. With the emergence of CBG as a promising biomarker, the future of detecting recent cannabis use is clearer than ever, promising safer roads and workplaces for everyone.
____________________________________________________________________________________________________
[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]____________________________________________________________________________________________________
What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!
With a professional background in CAD technical drawing (2D and 3D), João Xabregas is an activist and advocate for all uses and applications of cannabis. He discovered and entered the world of cannabis during his youth, where he developed a special interest in the cultivation of the plant, which led him on a journey of self-learning through the world of cannabis that continues to this day. His adventures linked to cannabis cultivation began with the same goal as many others: to be able to guarantee the quality and eliminate any possible risks to his health of what he consumed, as well as to avoid any type of dependence on the illicit market. However, he quickly began to view the world of cannabis and everything related to it with a very different perspective. He admits the enormous passion he has for the most persecuted plant in the world and about which he is always willing to write and have a good conversation.
